← FDA DRUG APPROVALS

FDA ANDA · ANDA070248

NITROFURANTOIN MACROCRYSTALLINE

Sponsor: WATSON LABS

APPLICATION
ANDA070248
TYPE
ANDA
LATEST ACTION
1989-05-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

NITROFURANTOIN MACROCRYSTALLINEDiscontinued
NITROFURANTOIN, MACROCRYSTALLINE 50MG · CAPSULE · ORAL

Approval history

1989-05-22Labeling · Supplement 5AP
1989-02-22Manufacturing (CMC) · Supplement 1AP
1988-12-23Manufacturing (CMC) · Supplement 3AP
1988-12-20Labeling · Supplement 2AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →